pre-miRNA Information
pre-miRNA hsa-mir-216b   
Genomic Coordinates chr2: 56000714 - 56000795
Description Homo sapiens miR-216b stem-loop
Comment This sequence was identified as a miRNA candidate by Berezikov et al. using RAKE and MPSS techniques .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-216b-5p
Sequence 11| AAAUCUCUGCAGGCAAAUGUGA |32
Evidence Experimental
Experiments Cloned
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs746268253 9 dbSNP
rs777165632 10 dbSNP
rs528642031 11 dbSNP
rs1168114631 14 dbSNP
rs559876972 16 dbSNP
rs1415888803 17 dbSNP
rs756876970 18 dbSNP
rs930279879 18 dbSNP
rs777776673 19 dbSNP
rs1182789155 21 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
B5PHM2 miR-216b Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Plasma MiRNA qPCR analyses
Gene Information
Gene Symbol DNAJB9   
Synonyms ERdj4, MDG-1, MDG1, MST049, MSTP049
Description DnaJ heat shock protein family (Hsp40) member B9
Transcript NM_012328   
Expression
Putative miRNA Targets on DNAJB9
3'UTR of DNAJB9
(miRNA target sites are highlighted)
>DNAJB9|NM_012328|3'UTR
   1 TTCTTATTCTATTCTCACTAAATCCAACTGGTTGACTCTTCCTCATTATCTTTGATGCTAAACAATTTTCTGTGAACTAT
  81 TTTGACAAGTGCATGATTTCACTTTAAACAATTTGATATAGCTATTAAATATATTTAAGGGTTTTTTTTTTTTGACAAAT
 161 TCAACATTCAACGAGTAGACAAAATGCTAATTATTTCCCTGATTAGGAAAGTTTCTTTAAAAAACACGTAATTTTGCCTA
 241 GTGCTTTTTCTCTACCTGCCCTTGGGCTCACTAATATCACCAGTATTATTACCAAGAAAATATTGAGTTTACCTGATTAA
 321 ACTTTAAAAGTTAATTGTAGATTTAAATTGTGTGAACCTAATGATTTTTGCAGTGAAACCTTTACTAATTCAAAGTTGCA
 401 TGTTCTATGACATCTGTGACTTGCGTTGCAGAGTGTACATGAAACTGTATAATTGAGTCATTCAGTAAAGGAGAACAGTA
 481 TCTTGGTTAATTGCTACTGAAAGGTTGAGAAAGGAATGGTTTGATATTTACCACAGCGCTGTGCCTTTCTACAGTAGAAC
 561 TGGGGTAAAGGAAATGGTTTTATTGCCCATAGTCATTTAGGCTGGAAAAAAGTTGAAAACTTAACGAAATATTGCCAAGA
 641 GATTGTTATGTGTTTGGTTCCAGCCTAAAAATGATTTTGTAGTGTTGAAATCATAGCTACTTACATAGCTTTTTCATATT
 721 TCTTTCTTAGTTGTTGGCACTCTTAGGTCTTAGTATGGATTTATGTGTTTGTGTGTGTGTAGTTTATCCTCTCTCTCATC
 801 TTTATCTAGAGATTGACTGATACCTCATTCTGTTTGTAAAACCAGCCAGTAATTTCTGTGCAACCTTACTATGTGCAATA
 881 TTTTTAAATCCTGAGAAATGTGTGCTTTTGTTTTCGGATAGACTTATTTCTTTAGTTCTGCACTTTTCCACATTATACTC
 961 CATATGAGTATTAATCCTATGGATACATATTAAAACAAGTGTCTCATACAACATTGTATGTGAGAGAAATATAAATATTT
1041 ACAACCTGATATTCGTTGTTGTTTTATTGTTAAAAGTTTATTATGCAACTCTGGAGGTATAGAGGGCATATAAGCTATGG
1121 GACATATGCTGATCACAGGCTATATTCATGAAGTTACTTTTGACCAACCTGAAAACTGATAGGATTTTGTTTGTCATTTG
1201 GTAATTTCTACTGCATTCTTACCATCCTTCTCTCACAAATTTTGATAGCTTGAAGATCTTTTTAATTATAATTTTGTTGT
1281 ATTTGTTTCCTAGGAGCAAGTGTTCCTGCTGCCAGTTCTTTCCTCTTTAGGCGTGGTTGAGAAAAAGCAGAAACTTTACA
1361 TAAAGCTGTATTTCTTAATCATCTTTAATTTGAAACTTAAGAAAATGAATTTATTCTGTTATATTTATGTAACTTATTTC
1441 CTGGAAGTTATATCTACTAGTTTTGTTTGATAATAATAAAATTAGCTATACCTTGAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agUGUA-AACGGACGUCUCUAAa 5'
            | || |||||   ||||||| 
Target 5' cgAAATATTGCC--AAGAGATTg 3'
625 - 645 156.00 -12.10
2
miRNA  3' agUGUAAACGGACGUCUCUAAa 5'
            |: ||| :||  ||||||| 
Target 5' tcATCTTTATCT--AGAGATTg 3'
796 - 815 156.00 -9.50
3
miRNA  3' agUGUAAACGGACG-UCUCUaaa 5'
            ||| |||: ||: |||||   
Target 5' caACA-TTGTATGTGAGAGAaat 3'
1009 - 1030 123.00 -9.02
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30694458 54 COSMIC
COSN19644387 87 COSMIC
COSN28080334 143 COSMIC
COSN1340339 154 COSMIC
COSN30172585 174 COSMIC
COSN25001297 208 COSMIC
COSN28880340 225 COSMIC
COSN1340341 260 COSMIC
COSN26093681 278 COSMIC
COSN31568450 297 COSMIC
COSN31526410 388 COSMIC
COSN29163215 406 COSMIC
COSN29859024 537 COSMIC
COSN31520161 690 COSMIC
COSN9918899 696 COSMIC
COSN6343020 741 COSMIC
COSN31553404 759 COSMIC
COSN31551432 832 COSMIC
COSN17875949 933 COSMIC
COSN15957897 1005 COSMIC
COSN7919908 1106 COSMIC
COSN25463944 1145 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs770071519 8 dbSNP
rs539029657 10 dbSNP
rs763361103 12 dbSNP
rs752039544 13 dbSNP
rs187252724 15 dbSNP
rs760165628 18 dbSNP
rs765822549 19 dbSNP
rs753446787 20 dbSNP
rs754671964 21 dbSNP
rs778748143 25 dbSNP
rs752517500 27 dbSNP
rs1261691651 28 dbSNP
rs371758437 29 dbSNP
rs945316053 32 dbSNP
rs1489346271 33 dbSNP
rs375296782 37 dbSNP
rs1403805932 38 dbSNP
rs961770465 40 dbSNP
rs1280745078 42 dbSNP
rs1254002403 45 dbSNP
rs368994075 45 dbSNP
rs770982059 46 dbSNP
rs781130127 49 dbSNP
rs1349056499 50 dbSNP
rs1294839027 51 dbSNP
rs934325936 53 dbSNP
rs1341765526 60 dbSNP
rs1469157139 61 dbSNP
rs1298315130 77 dbSNP
rs1156265127 80 dbSNP
rs1304933870 81 dbSNP
rs1466939369 92 dbSNP
rs1372997382 94 dbSNP
rs1168883960 103 dbSNP
rs192021096 110 dbSNP
rs1424360343 123 dbSNP
rs1054098392 125 dbSNP
rs1173569279 128 dbSNP
rs3763457 130 dbSNP
rs748551409 134 dbSNP
rs1412129891 139 dbSNP
rs996964896 139 dbSNP
rs763978989 140 dbSNP
rs1049615597 141 dbSNP
rs11408141 142 dbSNP
rs1232197871 142 dbSNP
rs1396015761 142 dbSNP
rs771340615 142 dbSNP
rs890863270 143 dbSNP
rs1396265365 146 dbSNP
rs1009053743 150 dbSNP
rs1335437829 154 dbSNP
rs1440327394 155 dbSNP
rs1276638611 156 dbSNP
rs1008168399 165 dbSNP
rs1345819313 166 dbSNP
rs1234930381 173 dbSNP
rs1279597781 178 dbSNP
rs1019066720 190 dbSNP
rs1164298542 191 dbSNP
rs962479862 198 dbSNP
rs1474300138 207 dbSNP
rs1370282439 211 dbSNP
rs1188424361 221 dbSNP
rs993770405 224 dbSNP
rs1028291555 226 dbSNP
rs751476171 227 dbSNP
rs757027606 228 dbSNP
rs980756568 229 dbSNP
rs926731037 230 dbSNP
rs1459010612 238 dbSNP
rs1258710202 242 dbSNP
rs1436816977 250 dbSNP
rs868648101 255 dbSNP
rs1179240963 257 dbSNP
rs1353578590 259 dbSNP
rs960781352 260 dbSNP
rs995470876 261 dbSNP
rs1334850837 271 dbSNP
rs1193543926 274 dbSNP
rs1026909685 289 dbSNP
rs1431981149 294 dbSNP
rs73428112 304 dbSNP
rs377765156 306 dbSNP
rs1325750961 314 dbSNP
rs1392922910 317 dbSNP
rs1408364477 317 dbSNP
rs3763456 323 dbSNP
rs945176171 327 dbSNP
rs1453295538 328 dbSNP
rs3763455 335 dbSNP
rs147964164 356 dbSNP
rs1302554627 362 dbSNP
rs978256942 373 dbSNP
rs773461640 380 dbSNP
rs1368653320 388 dbSNP
rs932363014 389 dbSNP
rs577345709 399 dbSNP
rs890914260 401 dbSNP
rs1209952260 403 dbSNP
rs1007933017 408 dbSNP
rs1241889425 412 dbSNP
rs546198697 420 dbSNP
rs1338513118 425 dbSNP
rs546419128 426 dbSNP
rs1434882573 433 dbSNP
rs1333383091 436 dbSNP
rs1324250528 439 dbSNP
rs1193715570 441 dbSNP
rs1054127719 446 dbSNP
rs1358850207 446 dbSNP
rs1291649357 450 dbSNP
rs183438831 452 dbSNP
rs914230809 459 dbSNP
rs1476980861 460 dbSNP
rs932457785 465 dbSNP
rs1212566956 469 dbSNP
rs1198932984 470 dbSNP
rs1445859992 471 dbSNP
rs1260414009 481 dbSNP
rs188843857 487 dbSNP
rs1218287015 493 dbSNP
rs542069377 494 dbSNP
rs1036703400 504 dbSNP
rs562265068 505 dbSNP
rs531133352 508 dbSNP
rs1194529330 509 dbSNP
rs954326608 515 dbSNP
rs890989263 522 dbSNP
rs994047435 527 dbSNP
rs1027937532 528 dbSNP
rs888020129 533 dbSNP
rs1036786604 538 dbSNP
rs897087497 539 dbSNP
rs1375108939 541 dbSNP
rs1002247238 542 dbSNP
rs1033685052 551 dbSNP
rs1412598149 552 dbSNP
rs1395549244 554 dbSNP
rs550830726 557 dbSNP
rs1173022178 559 dbSNP
rs1026983375 561 dbSNP
rs1461154159 564 dbSNP
rs1323918384 569 dbSNP
rs566651601 572 dbSNP
rs895121661 573 dbSNP
rs992258453 584 dbSNP
rs1390942725 590 dbSNP
rs1437107554 595 dbSNP
rs1444434522 603 dbSNP
rs1021435242 607 dbSNP
rs1195693004 609 dbSNP
rs1316623144 626 dbSNP
rs1296296589 627 dbSNP
rs1280135495 628 dbSNP
rs1012362688 632 dbSNP
rs1355040172 638 dbSNP
rs1282580865 639 dbSNP
rs570785153 640 dbSNP
rs1450469367 647 dbSNP
rs4727712 649 dbSNP
rs1225028602 650 dbSNP
rs1285559795 656 dbSNP
rs1334592688 664 dbSNP
rs1335031411 666 dbSNP
rs1025495174 683 dbSNP
rs779654673 694 dbSNP
rs748832814 700 dbSNP
rs559356585 706 dbSNP
rs1412466511 710 dbSNP
rs1179687514 716 dbSNP
rs768170424 717 dbSNP
rs1473594610 719 dbSNP
rs538965165 723 dbSNP
rs778162838 737 dbSNP
rs760865152 741 dbSNP
rs978666068 744 dbSNP
rs1178451536 747 dbSNP
rs1456819158 748 dbSNP
rs1260606572 754 dbSNP
rs1199832642 756 dbSNP
rs1031138301 762 dbSNP
rs958308561 765 dbSNP
rs747491232 767 dbSNP
rs1230189341 770 dbSNP
rs932566447 771 dbSNP
rs1284540781 775 dbSNP
rs1445861892 778 dbSNP
rs1374555859 779 dbSNP
rs985302952 784 dbSNP
rs912235150 789 dbSNP
rs914263682 789 dbSNP
rs943676756 794 dbSNP
rs879022721 800 dbSNP
rs1036799177 809 dbSNP
rs1445609783 814 dbSNP
rs879341784 814 dbSNP
rs1158402367 819 dbSNP
rs985113806 819 dbSNP
rs1438152451 820 dbSNP
rs912303300 823 dbSNP
rs1179768550 824 dbSNP
rs1488452983 827 dbSNP
rs1245030455 828 dbSNP
rs1322551752 830 dbSNP
rs1190006829 833 dbSNP
rs1419064494 838 dbSNP
rs1267359009 842 dbSNP
rs1474970388 843 dbSNP
rs896886017 843 dbSNP
rs1036859926 849 dbSNP
rs896991102 853 dbSNP
rs1366888053 859 dbSNP
rs1291280788 860 dbSNP
rs929526223 863 dbSNP
rs1163058188 864 dbSNP
rs931255458 873 dbSNP
rs1382503156 874 dbSNP
rs1159677479 881 dbSNP
rs1433079515 885 dbSNP
rs193080310 887 dbSNP
rs1423767353 902 dbSNP
rs1049694242 903 dbSNP
rs1454426769 910 dbSNP
rs1488815630 911 dbSNP
rs546176562 916 dbSNP
rs566451900 917 dbSNP
rs1380489147 919 dbSNP
rs1287868615 925 dbSNP
rs1335883755 927 dbSNP
rs879197346 928 dbSNP
rs1024934093 944 dbSNP
rs1033902627 946 dbSNP
rs1220873116 950 dbSNP
rs896507951 953 dbSNP
rs141839050 957 dbSNP
rs1397724320 961 dbSNP
rs1362108756 962 dbSNP
rs1021066578 963 dbSNP
rs1031211821 965 dbSNP
rs958173825 980 dbSNP
rs1239190141 987 dbSNP
rs989759587 993 dbSNP
rs1434287507 994 dbSNP
rs1422953650 997 dbSNP
rs1418030987 1004 dbSNP
rs1259667829 1008 dbSNP
rs1478909264 1011 dbSNP
rs1349107108 1021 dbSNP
rs753053113 1033 dbSNP
rs555294355 1036 dbSNP
rs1254056880 1046 dbSNP
rs1258576676 1047 dbSNP
rs1212089295 1050 dbSNP
rs1223060193 1055 dbSNP
rs147039924 1055 dbSNP
rs538024556 1056 dbSNP
rs1216327357 1066 dbSNP
rs985539760 1068 dbSNP
rs953844769 1069 dbSNP
rs777202119 1077 dbSNP
rs1485589098 1080 dbSNP
rs1377381430 1092 dbSNP
rs943824186 1098 dbSNP
rs985355283 1107 dbSNP
rs558113219 1109 dbSNP
rs1400270025 1110 dbSNP
rs912454372 1111 dbSNP
rs943728970 1118 dbSNP
rs1168623045 1125 dbSNP
rs756720560 1127 dbSNP
rs1186061100 1130 dbSNP
rs1467194651 1132 dbSNP
rs138263970 1134 dbSNP
rs1187052377 1135 dbSNP
rs2286259 1136 dbSNP
rs1048193710 1141 dbSNP
rs1183418956 1149 dbSNP
rs1461709567 1158 dbSNP
rs895056079 1159 dbSNP
rs1196688904 1162 dbSNP
rs947960741 1170 dbSNP
rs1251417595 1172 dbSNP
rs931061423 1185 dbSNP
rs1319607990 1186 dbSNP
rs1175438856 1189 dbSNP
rs1048112028 1190 dbSNP
rs1453921787 1197 dbSNP
rs1376640954 1207 dbSNP
rs887958331 1213 dbSNP
rs553294284 1224 dbSNP
rs1375831917 1225 dbSNP
rs906530414 1231 dbSNP
rs938138708 1242 dbSNP
rs999634007 1244 dbSNP
rs1052505746 1248 dbSNP
rs1055409709 1249 dbSNP
rs1166632075 1256 dbSNP
rs575130641 1264 dbSNP
rs1375019336 1266 dbSNP
rs1013625858 1269 dbSNP
rs1011097455 1270 dbSNP
rs1176660478 1275 dbSNP
rs1042779390 1281 dbSNP
rs1250592651 1282 dbSNP
rs754279101 1286 dbSNP
rs1391641431 1289 dbSNP
rs35515962 1294 dbSNP
rs113202530 1303 dbSNP
rs1266904276 1314 dbSNP
rs1001363431 1317 dbSNP
rs1333483350 1323 dbSNP
rs1236065506 1327 dbSNP
rs1353383632 1329 dbSNP
rs542283661 1333 dbSNP
rs562161357 1334 dbSNP
rs1336910012 1337 dbSNP
rs953897218 1341 dbSNP
rs1006658736 1351 dbSNP
rs1385219696 1356 dbSNP
rs185819843 1369 dbSNP
rs972345109 1380 dbSNP
rs1419362912 1381 dbSNP
rs965265264 1382 dbSNP
rs1156668322 1397 dbSNP
rs1441437154 1400 dbSNP
rs1176851722 1406 dbSNP
rs1248421862 1408 dbSNP
rs865909211 1412 dbSNP
rs757399391 1418 dbSNP
rs1197538904 1428 dbSNP
rs918356755 1431 dbSNP
rs80193567 1434 dbSNP
rs1195410222 1442 dbSNP
rs952384511 1444 dbSNP
rs143312141 1445 dbSNP
rs1434064656 1449 dbSNP
rs1219331940 1452 dbSNP
rs927011748 1453 dbSNP
rs916406981 1461 dbSNP
rs1046291804 1470 dbSNP
rs948002849 1470 dbSNP
rs533402952 1473 dbSNP
rs1356079691 1486 dbSNP
rs762977057 1487 dbSNP
rs1297319356 1488 dbSNP
rs935331177 1489 dbSNP
rs1052411161 1492 dbSNP
rs1393679275 1494 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection ...

- Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell.

Article - Hafner M; Landthaler M; Burger L; Khorshid et al.
- Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Disease 4189.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1 ...

- Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods.

Article - Kishore S; Jaskiewicz L; Burger L; Hausser et al.
- Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
Experimental Support 3 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions MCF7
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated ...

- Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology.

Article - Farazi TA; Ten Hoeve JJ; Brown M; et al.
- Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
CLIP-seq Support 1 for dataset GSM545216
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / miR-124 transfection
Location of target site ENST00000249356.3 | 3UTR | UUUAUCCUCUCUCUCAUCUUUAUCUAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM714645
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repB
Location of target site ENST00000249356.3 | 3UTR | UUAUCCUCUCUCUCAUCUUUAUCUAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset SRR1045082
Method / RBP PAR-CLIP / AGO2
Cell line / Condition MCF7 / Untreated
Location of target site ENST00000249356.3 | 3UTR | UUUAUCCUCUCUCUCAUCUUUAUCUAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 24398324 / SRX388831
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
LIHC 0.325 0.02 0.237 0.06 44 Click to see details
KIRC 0.647 0.08 0.314 0.27 6 Click to see details
LUSC -0.395 0.22 -0.143 0.39 6 Click to see details
KIRP 0.498 0.25 0.400 0.3 4 Click to see details
CHOL 0.337 0.26 -0.086 0.44 6 Click to see details
THCA 0.147 0.28 0.143 0.29 18 Click to see details
BLCA 0.431 0.28 0.400 0.3 4 Click to see details
UCEC -0.626 0.28 -0.500 0.33 3 Click to see details
PAAD 0.554 0.31 0.500 0.33 3 Click to see details
KICH 0.282 0.32 -0.100 0.44 5 Click to see details
STAD 0.219 0.34 0.257 0.31 6 Click to see details
HNSC 0.062 0.45 0.179 0.35 7 Click to see details
LUAD 0.162 0.45 0.500 0.33 3 Click to see details
PRAD -0.032 0.47 -0.297 0.2 10 Click to see details
PRAD -0.032 0.47 -0.297 0.2 10 Click to see details
PRAD -0.032 0.47 -0.297 0.2 10 Click to see details
PRAD -0.032 0.47 -0.297 0.2 10 Click to see details
PRAD -0.032 0.47 -0.297 0.2 10 Click to see details
PRAD -0.032 0.47 -0.297 0.2 10 Click to see details
129 hsa-miR-216b-5p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT006144 KRAS KRAS proto-oncogene, GTPase 3 1
MIRT007207 CSNK2A1 casein kinase 2 alpha 1 3 1
MIRT064260 KIAA1804 mitogen-activated protein kinase kinase kinase 21 2 2
MIRT169957 DNAJB9 DnaJ heat shock protein family (Hsp40) member B9 2 6
MIRT362970 CDK6 cyclin dependent kinase 6 2 2
MIRT437983 BECN1 beclin 1 3 2
MIRT443073 ABLIM1 actin binding LIM protein 1 2 2
MIRT443747 ZFAND5 zinc finger AN1-type containing 5 2 6
MIRT445488 KLF12 Kruppel like factor 12 2 2
MIRT447818 ZCCHC11 zinc finger CCHC-type containing 11 2 2
MIRT448753 HINT1 histidine triad nucleotide binding protein 1 2 2
MIRT460391 GUF1 GUF1 homolog, GTPase 2 2
MIRT466481 TECPR2 tectonin beta-propeller repeat containing 2 2 7
MIRT472205 NGFRAP1 brain expressed X-linked 3 2 4
MIRT473269 MID1 midline 1 2 2
MIRT489831 P2RY2 purinergic receptor P2Y2 2 2
MIRT497753 OXGR1 oxoglutarate receptor 1 2 2
MIRT502881 CDK4 cyclin dependent kinase 4 2 8
MIRT505904 RIMS3 regulating synaptic membrane exocytosis 3 2 6
MIRT506657 MAPK1 mitogen-activated protein kinase 1 2 4
MIRT510190 MON1B MON1 homolog B, secretory trafficking associated 2 4
MIRT512406 CD84 CD84 molecule 2 2
MIRT520342 UBXN2A UBX domain protein 2A 2 2
MIRT523602 FZD5 frizzled class receptor 5 2 2
MIRT529598 C6orf132 chromosome 6 open reading frame 132 2 2
MIRT534444 SDR16C5 short chain dehydrogenase/reductase family 16C member 5 2 2
MIRT534739 RBM47 RNA binding motif protein 47 2 2
MIRT537285 GABPB1 GA binding protein transcription factor beta subunit 1 2 2
MIRT546979 PRKAB2 protein kinase AMP-activated non-catalytic subunit beta 2 2 2
MIRT549862 MCM4 minichromosome maintenance complex component 4 2 2
MIRT552535 ZIC5 Zic family member 5 2 2
MIRT555322 PPP2CB protein phosphatase 2 catalytic subunit beta 2 2
MIRT555661 PGM3 phosphoglucomutase 3 2 2
MIRT559128 C11orf57 chromosome 11 open reading frame 57 2 2
MIRT567802 DEK DEK proto-oncogene 2 2
MIRT567866 DCAF12 DDB1 and CUL4 associated factor 12 2 2
MIRT574661 KLHL15 kelch like family member 15 2 2
MIRT575029 Tecpr2 tectonin beta-propeller repeat containing 2 2 5
MIRT607227 ACSM2A acyl-CoA synthetase medium chain family member 2A 2 4
MIRT609385 FAM216B family with sequence similarity 216 member B 2 4
MIRT612266 PDZD4 PDZ domain containing 4 2 2
MIRT617434 ANP32E acidic nuclear phosphoprotein 32 family member E 2 4
MIRT619453 NUP214 nucleoporin 214 2 2
MIRT620242 CCDC65 coiled-coil domain containing 65 2 2
MIRT620463 CENPN centromere protein N 2 2
MIRT620909 MUT methylmalonyl-CoA mutase 2 2
MIRT621006 C19orf52 translocase of inner mitochondrial membrane 29 2 2
MIRT621568 ZBTB7A zinc finger and BTB domain containing 7A 2 2
MIRT622059 SSBP2 single stranded DNA binding protein 2 2 2
MIRT622132 SP4 Sp4 transcription factor 2 2
MIRT623365 LZIC leucine zipper and CTNNBIP1 domain containing 2 2
MIRT624370 CDK12 cyclin dependent kinase 12 2 2
MIRT627944 NNT nicotinamide nucleotide transhydrogenase 2 2
MIRT628228 FBXL20 F-box and leucine rich repeat protein 20 2 2
MIRT630150 ZDHHC9 zinc finger DHHC-type containing 9 2 2
MIRT630237 SORD sorbitol dehydrogenase 2 2
MIRT631271 CENPM centromere protein M 2 2
MIRT637456 ZNF324B zinc finger protein 324B 2 2
MIRT637899 SLC19A3 solute carrier family 19 member 3 2 2
MIRT641610 CAPN7 calpain 7 2 2
MIRT643088 PTPLAD2 3-hydroxyacyl-CoA dehydratase 4 1 1
MIRT643813 ABCC12 ATP binding cassette subfamily C member 12 2 2
MIRT643911 TCEB2 elongin B 2 2
MIRT644900 ZBED1 zinc finger BED-type containing 1 2 2
MIRT645012 NGRN neugrin, neurite outgrowth associated 2 2
MIRT645521 ZWINT ZW10 interacting kinetochore protein 2 2
MIRT646032 S100A7A S100 calcium binding protein A7A 2 2
MIRT646626 CENPL centromere protein L 2 2
MIRT646721 RHOG ras homolog family member G 2 2
MIRT647196 ZNF583 zinc finger protein 583 2 2
MIRT648010 ZNF431 zinc finger protein 431 2 2
MIRT648362 AKIP1 A-kinase interacting protein 1 2 2
MIRT648400 WRN Werner syndrome RecQ like helicase 2 2
MIRT648833 C8orf37 chromosome 8 open reading frame 37 2 2
MIRT651870 UNC119B unc-119 lipid binding chaperone B 2 2
MIRT652490 TMEM178B transmembrane protein 178B 2 2
MIRT652529 TM9SF4 transmembrane 9 superfamily member 4 2 2
MIRT652536 TM9SF3 transmembrane 9 superfamily member 3 2 2
MIRT652795 TCEANC2 transcription elongation factor A N-terminal and central domain containing 2 2 2
MIRT653379 SMAD1 SMAD family member 1 2 2
MIRT655568 P2RX7 purinergic receptor P2X 7 2 2
MIRT657235 IER5 immediate early response 5 2 2
MIRT657594 GRIN2A glutamate ionotropic receptor NMDA type subunit 2A 2 2
MIRT658037 FZD9 frizzled class receptor 9 2 2
MIRT658151 FGF10 fibroblast growth factor 10 2 2
MIRT658459 FAM117B family with sequence similarity 117 member B 2 2
MIRT658503 EXOC5 exocyst complex component 5 2 2
MIRT659420 COL4A4 collagen type IV alpha 4 chain 2 2
MIRT660023 C1GALT1 core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 2 2
MIRT660032 C16orf52 chromosome 16 open reading frame 52 2 2
MIRT661206 MPPE1 metallophosphoesterase 1 2 2
MIRT661639 UGT2B28 UDP glucuronosyltransferase family 2 member B28 2 2
MIRT665303 ZBTB38 zinc finger and BTB domain containing 38 2 2
MIRT668010 HCFC2 host cell factor C2 2 2
MIRT673436 APAF1 apoptotic peptidase activating factor 1 2 2
MIRT673583 KDELC2 KDEL motif containing 2 2 2
MIRT673717 SLU7 SLU7 homolog, splicing factor 2 2
MIRT674315 IMP4 IMP4, U3 small nucleolar ribonucleoprotein 2 2
MIRT675811 MED28 mediator complex subunit 28 2 2
MIRT686564 TPM3 tropomyosin 3 2 2
MIRT687134 QPCTL glutaminyl-peptide cyclotransferase like 2 2
MIRT687463 NKD1 naked cuticle homolog 1 2 2
MIRT690226 C5orf45 MRN complex interacting protein 2 2
MIRT690532 ZNF566 zinc finger protein 566 2 2
MIRT693077 AS3MT arsenite methyltransferase 2 2
MIRT694083 RNASEH2B ribonuclease H2 subunit B 2 2
MIRT695388 NSA2 NSA2, ribosome biogenesis homolog 2 2
MIRT695638 SLC26A2 solute carrier family 26 member 2 2 2
MIRT696540 C3 complement C3 2 2
MIRT705522 ARL6IP1 ADP ribosylation factor like GTPase 6 interacting protein 1 2 2
MIRT711304 ACOX1 acyl-CoA oxidase 1 2 2
MIRT711513 ESCO1 establishment of sister chromatid cohesion N-acetyltransferase 1 2 2
MIRT711617 LHX5 LIM homeobox 5 2 2
MIRT711647 LIPG lipase G, endothelial type 2 2
MIRT711771 CCDC59 coiled-coil domain containing 59 2 2
MIRT713207 SOCS6 suppressor of cytokine signaling 6 2 2
MIRT715047 PRPF38A pre-mRNA processing factor 38A 2 2
MIRT715620 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT717677 CDC42BPA CDC42 binding protein kinase alpha 2 2
MIRT718016 METTL15 methyltransferase like 15 2 2
MIRT721251 KIAA0922 transmembrane 131 like 2 2
MIRT721438 ARPC4 actin related protein 2/3 complex subunit 4 2 2
MIRT722193 DNAJC9 DnaJ heat shock protein family (Hsp40) member C9 2 2
MIRT723319 PRKCH protein kinase C eta 2 2
MIRT725299 NLRC5 NLR family CARD domain containing 5 2 2
MIRT731866 HDAC8 histone deacetylase 8 3 1
MIRT731987 PARP1 poly(ADP-ribose) polymerase 1 3 1
MIRT735558 MALAT1 metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) 3 0
MIRT735826 SMAD3 SMAD family member 3 3 0
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-216b Perfluorooctane sulfonate NULL 74483 Microarray zebrafish embryos 20878907 2011 up-regulated
miR-216b 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) NULL 15625 Microarray embryos 22921993 2012 up-regulated
miR-216b Reversine NULL 210332 Microarray C2C12 myoblast cells 24513286 2014 up-regulated
miR-216b Hydroxycamptothecin (HCPT) NULL 97226 Microarray human Tenon's fibroblasts (HTFs) 24681041 2014 down-regulated
miR-216b Hydroxycamptothecin (HCPT) NULL 97226 Quantitative real-time PCR human Tenon's fibroblasts (HTFs) 24681041 2014 down-regulated
miR-216b Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-216b Doxorubicin approved 31703 Quantitative real-time PCR heart 22859947 2012 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-216b Paclitaxel 36314 NSC125973 approved sensitive cell line (A2780)
hsa-mir-216b Cisplatin 5460033 NSC119875 approved sensitive cell line (A2780)
hsa-miR-216b-5p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-216b-5p Verapamil 2520 NSC272366 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-216b-5p Cisplatin 5460033 NSC119875 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-216b-5p Oxaliplatin 6857599 NSC266046 approved sensitive Low Colorectal Cancer cell line (HT-29, HCT8)
hsa-miR-216b-5p Vemurafenib 42611257 NSC761431 approved sensitive Low Melanoma cell line (A375, G-361)
hsa-miR-216b-5p Cisplatin 5460033 NSC119875 approved sensitive Low Non-Small Cell Lung Cancer cell line (A549, PC-9)
hsa-miR-216b-5p Paclitaxel 36314 NSC125973 approved sensitive Low Prostate Cancer cell line (DU-145, PC-3)
hsa-miR-216b-5p Cisplatin 5460033 NSC119875 approved sensitive Low Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-216b-5p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) resistant High Metastatic Colorectal Cancer tissue
hsa-miR-216b-5p Carboplatin 38904 NSC241240 approved resistant Low Non-Small Cell Lung Cancer cell line (A549, NCI-H460)
hsa-miR-216b-5p Cisplatin 5460033 NSC119875 approved resistant Low Non-Small Cell Lung Cancer cell line (A549, NCI-H460)
hsa-miR-216b-5p Cisplatin 5460033 NSC119875 approved sensitive Low Osteosarcoma cell line (MG-63, SaOS-2)
hsa-miR-216b-5p Paclitaxel 36314 NSC125973 approved sensitive Low Ovarian Cancer cell line (A2780)
hsa-miR-216b-5p Gefitinib 123631 NSC715055 approved resistant cell line (PC9)
hsa-miR-216b-5p Osimertinib 71496458 NSC779217 approved resistant cell line (PC9)
hsa-miR-216b-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-216b-5p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-216b-5p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-216b-5p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM17)
hsa-miR-216b-5p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-216b-5p Paclitaxel 36314 NSC125973 approved sensitive cell line (A2780)
hsa-miR-216b-5p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-216b-5p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-216b-5p Oxaliplatin 6857599 NSC266046 approved resistant cell line (IGROV-1)
hsa-miR-216b-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-216b-5p Cetuximab resistant tissue (colorectal carcinoma)

Error report submission